These reactions are generally mild and resolve on their own, but they are a consideration for those administering the medication
Saxenda 6 mg/mL solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)
J Neurol 270(2):851863 Wharton S et al (2022) Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
supply chain, while carving out an exception for manufacturers that appear compliant based on inspections or other evaluation
(And weight loss is not a federally approved use of Ozempic, despite its popularity, though similar drugs of different dosages are approved for obesity treatment.) But now that these drugs are in greater demand from both patients and doctors, state Medicaid programs are grappling with whether to cover them for weight loss, both for reasons of equity and to save on future health expenditures
In addition to pharmacological intervention, patients are usually advised to continue with lifestyle modifications, such as a balanced diet and regular exercise
